p irf3 (Cell Signaling Technology Inc)


Structured Review

P Irf3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p irf3/product/Cell Signaling Technology Inc
Average 95 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Apoptotic tumor cell-derived microparticles loading Napabucasin inhibit CSCs and synergistic immune therapy"
Article Title: Apoptotic tumor cell-derived microparticles loading Napabucasin inhibit CSCs and synergistic immune therapy
Journal: Journal of Nanobiotechnology
doi: 10.1186/s12951-023-01792-8

Figure Legend Snippet: In vivo validation of the mechanism of NAP inhibiting colon cancer. A The KEGG enrichment analysis indicated that the immune-related pathway was regulated after TMPs treatment. B GSEA algorithm was used to analyze the changes in the cytosolic DNA-sensing pathway after TMPs treatment. C p-TBK1(Ser172) and p-IRF3(Ser386), markers of activation of innate immune pathway cytosolic DNA-sensing, were detected after TMPs treatment. D – F RT-qPCR detected downstream target genes of the DNA-sensing pathway. G – H Representative flow analysis of CD3 + CD4 + T cells and CD3 + CD8 + T cells in tumor tissues. I – J Representative fluorescent images of CD3 + CD4 + T cells and CD3 + CD8 + T cells in tumor tissues. (n = 6, scale bars:100 μm)
Techniques Used: In Vivo, Activation Assay, Quantitative RT-PCR
p irf3 ser396 (Cell Signaling Technology Inc)


Structured Review

P Irf3 Ser396, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p irf3 ser396/product/Cell Signaling Technology Inc
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Ste20-Like Kinase TAOK1 Positively Regulates Antiviral Responses by Controlling the TBK1-IRF3 Signaling Axis"
Article Title: Ste20-Like Kinase TAOK1 Positively Regulates Antiviral Responses by Controlling the TBK1-IRF3 Signaling Axis
Journal: Journal of Innate Immunity
doi: 10.1159/000526324

Figure Legend Snippet: TAOK1 deficiency inhibits VSV-induced IKKε and IRF3 phosphorylation. a , b Immunoblot analysis of phosphorylated and total proteins in lysates of PMs obtained from WT (TAOK1 f/f ) and TAOK1cko (Lyz2 + TAOK1 f/f ) mice infected with VSV for indicated time. c Immunoblot analysis of phosphorylated and total proteins in lysates of Myc-TAOK1 overexpressing RAW264.7 macrophages infected with VSV for indicated time. d Luciferase activity in HEK293T cells transfected with Ifnb luciferase reporter, a Renilla-TK reporter, and an expression vector for TAOK1, along with plasmids encoding RIG-I N, TBK1, IKKε, and IRF3 5D. Data are representative of three independent experiments. Data are mean ± SD. * p < 0.05, ** p < 0.01 (Student's t test). ns, not significant.
Techniques Used: Western Blot, Infection, Luciferase, Activity Assay, Transfection, Expressing, Plasmid Preparation
![... cells that co-transfected with Myc-TAOK1 plus HA-TBK1 or HA-IRF3 plasmids, then immunoprecipitated with antibody to HA tag. ... TAOK1 interacts with TBK1. a Mouse PMs (from wild-type [WT] C57BL/6 mice, 6–8 weeks old) were infected with VSV for indicated hours. Immunoblot analysis of endogenous signal adapters immunoprecipitated with antibody to TAOK1. b Immunoblot analysis of HEK293T cells that co-transfected with Myc-TAOK1 plus HA-TBK1 or HA-IRF3 plasmids, then immunoprecipitated with antibody to HA tag. c Immunoblot analysis of HEK293T cells that co-transfected with Myc-TAOK1 plus Flag-RIG-I plasmids, then immunoprecipitated with the antibody to Flag tag. d Immunoblot analysis of HEK293T cells that co-transfected with Myc-TAOK1 plus HA-MAVS plasmids, then immunoprecipitated with the antibody to HA tag. e WT and MAVS-deficient HEK293T (MAVS-KO) cells were infected with VSV for indicated time, followed by immunoprecipitation (IP) with anti-TAOK1 and immunoblot analysis with indicated antibodies. f Q-PCR analysis of IFNB1 and TNFA mRNA expression in MAVS-deficient HEK293T (MAVS-KO) cells transfected with TAOK1 expressing plasmid and infected with VSV for indicated time. Data are from one experiment of three similar results. Data are mean ± SD. * p < 0.05, ** p < 0.01 (Student's t test). WCL, whole-cell lysates; nd, not detected.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_5707/pmc10015707/pmc10015707__jin-0015-0380-g05.jpg)
Figure Legend Snippet: TAOK1 interacts with TBK1. a Mouse PMs (from wild-type [WT] C57BL/6 mice, 6–8 weeks old) were infected with VSV for indicated hours. Immunoblot analysis of endogenous signal adapters immunoprecipitated with antibody to TAOK1. b Immunoblot analysis of HEK293T cells that co-transfected with Myc-TAOK1 plus HA-TBK1 or HA-IRF3 plasmids, then immunoprecipitated with antibody to HA tag. c Immunoblot analysis of HEK293T cells that co-transfected with Myc-TAOK1 plus Flag-RIG-I plasmids, then immunoprecipitated with the antibody to Flag tag. d Immunoblot analysis of HEK293T cells that co-transfected with Myc-TAOK1 plus HA-MAVS plasmids, then immunoprecipitated with the antibody to HA tag. e WT and MAVS-deficient HEK293T (MAVS-KO) cells were infected with VSV for indicated time, followed by immunoprecipitation (IP) with anti-TAOK1 and immunoblot analysis with indicated antibodies. f Q-PCR analysis of IFNB1 and TNFA mRNA expression in MAVS-deficient HEK293T (MAVS-KO) cells transfected with TAOK1 expressing plasmid and infected with VSV for indicated time. Data are from one experiment of three similar results. Data are mean ± SD. * p < 0.05, ** p < 0.01 (Student's t test). WCL, whole-cell lysates; nd, not detected.
Techniques Used: Infection, Western Blot, Immunoprecipitation, Transfection, FLAG-tag, Expressing, Plasmid Preparation

Figure Legend Snippet: TAOK1 promotes TBK1-IRF3 complex formation. a HEK293T cells were transfected with plasmids encoding HA-TBK1, Flag-IRF3, and varying doses of a plasmid encoding Myc-TAOK1 (0.5, 1.0, and 1.5 μg). Cells were harvested 24 h after transfection for immunoblot analysis as indicated with the antibody to Flag tag. b HEK293T cells were transfected with plasmids encoding Flag-IKKε, HA-IRF3, and varying doses of a plasmid encoding Myc-TAOK1 (0.5, 1.0, and 1.5 μg). Cells were harvested 24 h after transfection for immunoblot analysis as indicated with antibody to HA tag. c Mouse PMs from WT (TAOK1 f/f ) and TAOK1cko (Lyz2 + TAOK1 f/f ) mice were infected with VSV for indicated hours. Immunoblot analysis of endogenous IRF3 immunoprecipitated with antibody to TBK1. Data are from one experiment of three similar results. * p < 0.05, ** p < 0.01. WCL, whole-cell lysates; ns, not significant.
Techniques Used: Transfection, Plasmid Preparation, Western Blot, FLAG-tag, Infection, Immunoprecipitation

Figure Legend Snippet: TAOK1 promotes the interaction between TBK1 and IRF3 by trafficking TBK1 along microtubules. a HeLa cells co-transfected with Flag-IRF3 and Myc-TAOK1 plasmids, then pretreated with DMSO or colchicine (10 μm) for 1 h, followed by infection with or without VSV for 4 h. Confocal microscopy of co-localization between Flag-IRF3 (green) and endogeneous TBK1 (red). DAPI served as a marker of nuclei (blue). Scale bar, 10 μm. b Confocal microscopy of HeLa cells transfected with Myc-TAOK1, Myc-TAOK1 K57A, Myc-TAOK1C, and Myc-TAOK1N plasmids (green) followed by VSV infection for 4 h α-tubulin (red) was used to probe the microtubules. DAPI served as a marker of nuclei (blue). Scale bar, 10 μm. c Immunoblot analysis of phosphorylated and total MAP4 proteins in lysates of PMs obtained from WT (TAOK1 f/f ) and TAOK1cko (Lyz2 + TAOK1 f/f ) mice infected with VSV for indicated time. d Mouse PMs were pretreated with DMSO or colchicine (10 μm) for 1 h and then infected with VSV for 4 h. Immunoblot analysis of phosphorylated and total IRF3 and MAP4 proteins in cell lysates. e Mouse PMs were pretreated with DMSO or colchicine (10 μM) for 1 h and then infected with VSV for 4 h. Immunoblot analysis of endogenous signal adapters immunoprecipitated with antibody to TAOK1. * p < 0.05, ** p < 0.01. Data are representative of three independent experiments with similar results. ns, not significant; WCL, whole-cell lysates.
Techniques Used: Transfection, Infection, Confocal Microscopy, Marker, Western Blot, Immunoprecipitation

Figure Legend Snippet: A schematic diagram revealing the proposed mechanism by which TAOK1 positively regulates antiviral immune responses. (1) TAOK1 promoted virus-induced MAP4 phosphorylation and microtubule detachment; (2) TAOK1 bound more dynein instead of MAP4 upon virus infection and promoted the perinuclear transport of TBK1 along microtubules; (3) TAOK1 positively regulated antiviral signaling by promoting the TBK1-IRF3 interaction and IRF3 phosphorylation.
Techniques Used: Infection
p irf3 (Cell Signaling Technology Inc)


Structured Review
P Irf3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p irf3/product/Cell Signaling Technology Inc
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
p irf3 s396 (Cell Signaling Technology Inc)


Structured Review
P Irf3 S396, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p irf3 s396/product/Cell Signaling Technology Inc
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
anti p interferon regulatory factor 3 p irf3 (Cell Signaling Technology Inc)


Structured Review
Anti P Interferon Regulatory Factor 3 P Irf3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti p interferon regulatory factor 3 p irf3/product/Cell Signaling Technology Inc
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
anti p irf3 monoclonal antibody (Cell Signaling Technology Inc)


Structured Review

Anti P Irf3 Monoclonal Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti p irf3 monoclonal antibody/product/Cell Signaling Technology Inc
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Innate sensing of picornavirus infection involves cGAS-STING-mediated antiviral responses triggered by mitochondrial DNA release"
Article Title: Innate sensing of picornavirus infection involves cGAS-STING-mediated antiviral responses triggered by mitochondrial DNA release
Journal: PLOS Pathogens
doi: 10.1371/journal.ppat.1011132

Figure Legend Snippet: (A) HEK-293T cells were transfected with 1 μg of empty vector or the indicated FLAG-2C-expressing plasmids, along with 1 μg of empty vector or HA-cGAS plus HA-STING expressing plasmids. At 24 hpt, the IFN-β protein amount in the supernatant was determined by ELISA, and the expression of 2C was confirmed by Western blotting. (B) STING-HEK-293T cells were transfected with increasing amount (0, 3, or 6 μg) of the indicated FLAG-2C-expressing plasmids. At 24 hpt, cells were transfected with poly(dA:dT) (2 μg/ml) for 12 h. The cells lysates were immunoprecipitated with anti-STING antibody. The antibody-antigen complexes were detected using anti-STING, TBK1, and FLAG antibodies, respectively. (C) Schematic representation of the structure and conserved functional sites in EV-A71 2C protein. The redder the color was, the more conservative the sites were. (D, E) HEK-293T cells were transfected with 1 μg of empty vector or EV-A71 (D), CA16 (E), and EMCV (E) FLAG-2C- or FLAG-2C mutants-expressing plasmids, along with 1 μg of empty vector or HA-cGAS plus HA-STING expressing plasmids. At 24 hpt, the IFN-β protein amount in the supernatant was determined by ELISA, and the expression of 2C was confirmed by Western blotting. (F) STING-HEK-293T cells were transfected with 6 μg of empty vector, FLAG-2C- or FLAG-2C mutants-expressing plasmids. At 24 hpt, cells were transfected with poly(dA:dT) (2 μg/ml) for 12 h. The cells lysates were immunoprecipitated with anti-STING antibody. The antibody-antigen complexes were detected using anti-STING, TBK1, and FLAG antibodies, respectively. (G) HEK-293T cells were transfected with 1 μg of empty vector, FLAG-2C- or FLAG-2C mutants-expressing plasmids, and 1 μg of HA-cGAS plus HA-STING expressing plasmids. At 24 hpt, expression of IRF3, p-IRF3, and FLAG-2C protein was determined by Western blotting. The IRF3 dimerization was detected using native PAGE. Error bars show standard deviation. **, P <0.01.
Techniques Used: Transfection, Plasmid Preparation, Expressing, Enzyme-linked Immunosorbent Assay, Western Blot, Immunoprecipitation, Functional Assay, Clear Native PAGE, Standard Deviation
p irf3 (Cell Signaling Technology Inc)


Structured Review

P Irf3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p irf3/product/Cell Signaling Technology Inc
Average 95 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Apoptotic tumor cell-derived microparticles loading Napabucasin inhibit CSCs and synergistic immune therapy"
Article Title: Apoptotic tumor cell-derived microparticles loading Napabucasin inhibit CSCs and synergistic immune therapy
Journal: Journal of Nanobiotechnology
doi: 10.1186/s12951-023-01792-8

Figure Legend Snippet: In vivo validation of the mechanism of NAP inhibiting colon cancer. A The KEGG enrichment analysis indicated that the immune-related pathway was regulated after TMPs treatment. B GSEA algorithm was used to analyze the changes in the cytosolic DNA-sensing pathway after TMPs treatment. C p-TBK1(Ser172) and p-IRF3(Ser386), markers of activation of innate immune pathway cytosolic DNA-sensing, were detected after TMPs treatment. D – F RT-qPCR detected downstream target genes of the DNA-sensing pathway. G – H Representative flow analysis of CD3 + CD4 + T cells and CD3 + CD8 + T cells in tumor tissues. I – J Representative fluorescent images of CD3 + CD4 + T cells and CD3 + CD8 + T cells in tumor tissues. (n = 6, scale bars:100 μm)
Techniques Used: In Vivo, Activation Assay, Quantitative RT-PCR
p irf3 (Cell Signaling Technology Inc)


Structured Review
P Irf3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p irf3/product/Cell Signaling Technology Inc
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
p irf3 (Cell Signaling Technology Inc)


Structured Review

P Irf3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p irf3/product/Cell Signaling Technology Inc
Average 92 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "A p53-TLR3 axis ameliorates pulmonary hypertension by inducing BMPR2 via IRF3"
Article Title: A p53-TLR3 axis ameliorates pulmonary hypertension by inducing BMPR2 via IRF3
Journal: iScience
doi: 10.1016/j.isci.2023.105935

Figure Legend Snippet: Clonal expansion requires loss of p53, and p53 regulates TLR3 expression in rat lung CD117 + ECs and EC clones and human pulmonary artery ECs from PAH patients (A and B) qRT-PCR data show lower Tp53 and Tlr3 expression after four generations of clonal expansion in CD117 + lin − CD31 + rat lung ECs. (C) Clonal expansion was vastly reduced in CD117 + rat lung ECs when treated for 14 days with Nutlin 3a, which inhibits p53 protein degradation. Figures indicate the number of wells that yielded colonies from a single cell after 14 days. n = 4 per group. (D) qRT-PCR shows reduced mRNA expression of Tp53 , Tlr3 , and Id1 following siRNA targeting p53 versus control (scrambled, scrm) siRNA in rat lung CD117 + ECs. n = 5–6. (E and F) Representative images (scale bar: 250 μm, stitched images) and quantification of total network area and network length from 2D matrigel tube formation assay in CD117 + rat lung ECs after treatment with siRNA targeting p53 or scrambled (scrm) unspecific siRNA. n = 4 per group. (G and H) Representative western blots (G) and quantification of three independent experiments (H) show p53 protein accumulation following treatment with the MDM2 inhibitor Nutlin 3a. n = 9 per group total. (I) qRT-PCR shows increased expression of Tlr3 , Mdm2 , and Id1 following Nutlin 3a treatment. n = 6 per group. (J and K) Representative images (scale bar: 250 μm, stitched images) and quantification of total network area and network length in rat lung CD117 + fourth generation EC clones after treatment with Nutlin 3a or vehicle. n = 5 per group. (L and N) Representative western blots of p53, TLR3, BMPR2, phospho-(p)-IRF3, and p-Smad1/5/9 (L) and densitometric quantification of p53, TLR3, and BMPR2 from 2 independent experiments (n = 3 each) in PAECs from PAH patients following Nutlin 3a or vehicle treatment for 24 h. (O) qRT-PCR shows increased TLR3 mRNA expression following Nutlin 3a treatment in PAH PAECs. n = 5 per group. (P) Quantification of total network area and network length in PAH PAECs after treatment with Nutlin 3a or vehicle. n = 10 per group. Quantification data are n-fold of the arithmetic mean of veh. (Q) Clonal expansion was vastly reduced in PAECs following 14 days of treatment with Nutlin 3a. Figures indicate the number of wells that yielded colonies from a single cell after 14 days. n = 4 per group. All values are expressed as mean ± SEM. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001 (t test). See also
Techniques Used: Expressing, Clone Assay, Quantitative RT-PCR, Tube Formation Assay, Western Blot

Figure Legend Snippet: Increased TLR3 signaling promotes BMPR2 signaling in p53-deficient PAECs (A and B) Representative histograms of 5-bromodesoxyuridine (BrdU) pulsed (4h) and BrdU-antibody-stained (AF647) PAECs treated with adenoviruses expressing sh-scrm (control sh RNA), sh-TP53, and sh-TP53 combined with 25 μg/mL Poly(I:C). (B) Quantification from 2 different cell lines (total n = 6 each). Data indicate increased DNA synthesis in sh-TP53 cells, which is reduced by Poly(I:C). Data are shown after normalization to the arithmetic mean of the sh-scrm group. (C and D) Representative phase contrast images (scale bar: 500 μm, stitched images, C) and quantification of total network area and network length (D) in rat lung CD117 + fourth generation EC clones after treatment with Nutlin 3a or vehicle. Two different cell lines (total n = 12 each). Data are shown after normalization to the arithmetic mean of the sh-scrm group. (E and F) Western blots (E) and densitometric quantification (F) of TLR3, p-IRF3, BMPR2, p-Smad1/5/9, and Smad1 in PAECs treated with sh-scrm, sh-TP53, and sh-TP53 + Poly(I:C). The results have been expressed as a ratio of the loading control β-actin and normalized to the arithmetic mean of the sh-scrm group. (G) qRT-PCR quantification of steady-state mRNA levels of TP53 , TLR3 , CXCL10 , BMP2 , and BMP4 . The results are expressed as a ratio of the housekeeping gene and normalized to the arithmetic mean of the sh-scrm group. The data are shown as single data points and mean ± SEM. Data are shown as single data points and mean ± SEM. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001 (one-way ANOVA).
Techniques Used: Staining, Expressing, DNA Synthesis, Clone Assay, Western Blot, Quantitative RT-PCR
![TLR3/IRF3 signaling maintains lung endothelial BMPR2 expression in vitro (A and B) Representative western blots (A) and densitometric quantification (B) of TLR3, BMPR2, and p-Smad1/5/9 in rat lung CD117 + ECs treated with sh-scrm (control-shRNA) and sh-Tlr3 (shRNA targeting Tlr3). The results have been expressed as a ratio of the loading control β-actin and normalized to the arithmetic mean of the sh-scrm group. The data are expressed as mean ± SEM. (C) qRT-PCR shows reduced Tlr3 and Bmpr2 steady-state mRNA level after sh-Tlr3 treatment of rat lung CD117 + ECs. The results have been expressed as a ratio of the housekeeping gene and normalized to the arithmetic mean of the sh-scrm group. The data are shown as mean ± SEM. (D and E) Representative immunoblot (D) and densitometric quantification (E) confirm the efficiency of the TLR3 CRISPR/cas9 gene editing in human PAECs. (F and G) Representative differential interference contrast (DIC) images (stitched by software) (F) and quantification of total network area and network length (G) in control PAECs that underwent gene editing using CRISPR/Cas9 technology with sgRNA targeting TLR3 or unspecific (scrm) sgRNA. The results have been normalized to the arithmetic mean of the scrm sgRNA group. Scale bar: 500μm. (H and I) Representative western blots (H) and densitometric quantification (I) indicate reduced BMPR2 expression in IRF3 siRNA-treated PAECs. The results have been normalized to the arithmetic mean of the si scrm group. (J) Diagram showing the location targeted by the primers pairs for qPCR amplification after chromatin immunoprecipitation (ChIP) for the predicted IRF3 binding sites (1A-C and 2A-C) upstream of the human BMPR2 TSS. The Eukaryotic Promoter Database, which was used for consensus site prediction, provided two version of the human BMPR2 promoter, BMPR2_1 and BMPR2_2 , with different starting positions on the chromosome. (K) ChIP qPCR indicates IRF3 chromatin immunoprecipitation and amplification of predicted consensus sites with the specific IRF3 antibody, but not with IgG control antibody, suggesting specific binding of IRF3 at the predicted consensus sites. In addition, Poly(I:C) treatment (25 μg/mL, 24h) promoted IRF3 binding (=amplification) at all consensus sites upstream of BMPR2 TSS. Because of the number of potential consensus sites, data from all consensus sites were integrated for analysis using two-way ANOVA, demonstrating a significant increase in IRF3 binding with Poly(I:C) treatment [p = 0.0049 Poly(I:C) versus control]. Data are shown as single data points and mean ± SEM. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 (t test). See also <xref ref-type=](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_2960/pmc09852960/pmc09852960__gr6.jpg)
Figure Legend Snippet: TLR3/IRF3 signaling maintains lung endothelial BMPR2 expression in vitro (A and B) Representative western blots (A) and densitometric quantification (B) of TLR3, BMPR2, and p-Smad1/5/9 in rat lung CD117 + ECs treated with sh-scrm (control-shRNA) and sh-Tlr3 (shRNA targeting Tlr3). The results have been expressed as a ratio of the loading control β-actin and normalized to the arithmetic mean of the sh-scrm group. The data are expressed as mean ± SEM. (C) qRT-PCR shows reduced Tlr3 and Bmpr2 steady-state mRNA level after sh-Tlr3 treatment of rat lung CD117 + ECs. The results have been expressed as a ratio of the housekeeping gene and normalized to the arithmetic mean of the sh-scrm group. The data are shown as mean ± SEM. (D and E) Representative immunoblot (D) and densitometric quantification (E) confirm the efficiency of the TLR3 CRISPR/cas9 gene editing in human PAECs. (F and G) Representative differential interference contrast (DIC) images (stitched by software) (F) and quantification of total network area and network length (G) in control PAECs that underwent gene editing using CRISPR/Cas9 technology with sgRNA targeting TLR3 or unspecific (scrm) sgRNA. The results have been normalized to the arithmetic mean of the scrm sgRNA group. Scale bar: 500μm. (H and I) Representative western blots (H) and densitometric quantification (I) indicate reduced BMPR2 expression in IRF3 siRNA-treated PAECs. The results have been normalized to the arithmetic mean of the si scrm group. (J) Diagram showing the location targeted by the primers pairs for qPCR amplification after chromatin immunoprecipitation (ChIP) for the predicted IRF3 binding sites (1A-C and 2A-C) upstream of the human BMPR2 TSS. The Eukaryotic Promoter Database, which was used for consensus site prediction, provided two version of the human BMPR2 promoter, BMPR2_1 and BMPR2_2 , with different starting positions on the chromosome. (K) ChIP qPCR indicates IRF3 chromatin immunoprecipitation and amplification of predicted consensus sites with the specific IRF3 antibody, but not with IgG control antibody, suggesting specific binding of IRF3 at the predicted consensus sites. In addition, Poly(I:C) treatment (25 μg/mL, 24h) promoted IRF3 binding (=amplification) at all consensus sites upstream of BMPR2 TSS. Because of the number of potential consensus sites, data from all consensus sites were integrated for analysis using two-way ANOVA, demonstrating a significant increase in IRF3 binding with Poly(I:C) treatment [p = 0.0049 Poly(I:C) versus control]. Data are shown as single data points and mean ± SEM. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 (t test). See also
Techniques Used: Expressing, In Vitro, Western Blot, shRNA, Quantitative RT-PCR, CRISPR, Software, Amplification, Chromatin Immunoprecipitation, Binding Assay

Figure Legend Snippet:
Techniques Used: Clone Assay, Isolation, Recombinant, Plasmid Preparation, Microscopy, Electron Microscopy, Amplification, SYBR Green Assay, Software
rabbit anti p irf3 antibody (Cell Signaling Technology Inc)


Structured Review

Rabbit Anti P Irf3 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti p irf3 antibody/product/Cell Signaling Technology Inc
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Avian Metapneumovirus Subgroup C Phosphoprotein Suppresses Type I Interferon Production by Blocking Interferon Regulatory Factor 3 Nuclear Translocation"
Article Title: Avian Metapneumovirus Subgroup C Phosphoprotein Suppresses Type I Interferon Production by Blocking Interferon Regulatory Factor 3 Nuclear Translocation
Journal: Microbiology Spectrum
doi: 10.1128/spectrum.03413-22

Figure Legend Snippet: aMPV P protein targets IRF7 for inhibiting IFN-β activation in DF-1 cells. (A and B) DF-1 cells were cotransfected with IRF7-luc or NF-κB-luc and pRL-TK, expression plasmid P (HA-P), or empty plasmid (HA). At 24 hpt, the cells were transfected with poly (I·C) for 12 h and subsequently subjected to luciferase activity measurement. The expressions of HA-tag protein and β-actin were detected by Western blotting. (C to F) DF-1 cells were cotransfected with MDA5, MAVS, TBK1, or IRF7 expression plasmids or empty plasmid (HA), IFN-β-luc, and pRL-TK. At 36 hpt, the cells were processed and the luciferase activity measured. The expression of HA-tag protein and Flag-tag protein were detected by Western blotting. Values are presented as the mean ± SD from three independent experiments. Statistical analysis was performed using Student's t test (ns, P > 0.05; ****, P < 0.0001).
Techniques Used: Activation Assay, Expressing, Plasmid Preparation, Transfection, Luciferase, Activity Assay, Western Blot, FLAG-tag

Figure Legend Snippet: aMPV P protein interacted with IRF7. (A and B) HEK-293T cells were cotransfected with GFP-P and Flag-IRF7 expression plasmids for 36 h. The cells were processed, immunoprecipitated with anti-GFP, anti-Flag, or anti-β-actin antibody, and subsequently analyzed using Western blotting with anti-Flag, anti-GFP, or anti-β-actin antibody. (C) DF-1 cells were cotransfected with GFP-P and/or Flag-IRF7 expression plasmids for 36 h, fixed, and processed. Dual labeling for GFP-P (green) and Flag-IRF7 (red) were observed by immunostaining with anti-Flag antibody. Cell nuclei were stained with DAPI (blue). The yellow observed in the merged images was considered to indicate colocalization areas. Scale bars, 20 μm. (D) DF-1 cells were transfected with Flag-IRF7 or Flag expression plasmids for 12 h, followed by infection with aMPV/C for 72 h. The cells were processed, immunoprecipitated with anti-Flag antibody, and subsequently analyzed using Western blotting with anti-Flag or anti-P antibody. (E) DF-1 cells were treated with Flag-IRF7 or Flag plasmids and aMPV/C as described in
Techniques Used: Expressing, Immunoprecipitation, Western Blot, Labeling, Immunostaining, Staining, Transfection, Infection

Figure Legend Snippet: aMPV P protein targets IRF3 for inhibiting IFN-β activation in HEK-293T cells. (A) HEK-293T cells cotransfected with IRF3-luc, pRL-TK, expression plasmid P (HA-P), or empty plasmid (HA). At 24 hpt, the cells were transfected with poly (I·C) for 12 h and the luciferase activity measured; the expression of HA-tag protein and β-actin were detected using Western blotting. (B) HEK-293T cells were transfected with expression plasmid P (GFP-P) or empty plasmid (GFP). At 24 hpt, the cells were transfected with poly (I·C) for 12 h, and the expression of IRF3 mRNA was measured using RT-qPCR. (C and D) HEK-293T cells were cotransfected with GFP-P and Flag-IRF3 expression plasmids for 36 h. The cells were processed, immunoprecipitated with anti-GFP, anti-Flag, or anti-β-actin antibody, and analyzed using Western blotting with anti-Flag, anti-GFP, or anti-β-actin antibody. (C and D) HEK-293T cells were cotransfected with GFP-P and Flag-IRF3 expression plasmids for 36 h. The cells were processed, immunoprecipitated with anti-GFP or anti-Flag antibody, and subsequently analyzed using Western blotting with anti-Flag or anti-GFP antibody. (E and F) HEK-293 or A549 cells were cotransfected with GFP-P and/or Flag-IRF3 expression plasmids for 36 h, fixed, and processed. The dual labeling for GFP-P (green) and Flag-IRF3 (red) was observed using immunostaining with anti-Flag antibody. Cell nuclei were stained with DAPI (blue). The yellow observed in the merged images is considered to indicate colocalization areas. Scale bars, 20 μm. Values are presented as the mean ± SD from three independent experiments. Statistical analysis was performed using Student's t test (**, P < 0.01; ****, P < 0.0001).
Techniques Used: Activation Assay, Expressing, Plasmid Preparation, Transfection, Luciferase, Activity Assay, Western Blot, Quantitative RT-PCR, Immunoprecipitation, Labeling, Immunostaining, Staining

Figure Legend Snippet: aMPV/C P protein (101 to 200 aa) interacts with IRF3. (A) Schematic representation of aMPV/C P protein (aa 1 to 295) and various truncated P proteins (aa 1 to 200, aa 101 to 295, aa 1 to 100, aa 101 to 200, and aa 201 to 295). (B) HEK-293T cells were cotransfected with GFP-P, GFP-P (1 to 200 aa), or GFP-P (101 to 295 aa) and Flag-IRF3 plasmids for 36 h. The cells were processed, immunoprecipitated with anti-Flag antibody, and analyzed using Western blotting with anti-Flag, anti-GFP antibody, or anti-β-actin. (C) HEK-293T cells were cotransfected with GFP-P, GFP-P (1 to 100 aa), GFP-P (101 to 200 aa), or GFP-P (1 to 200 aa) and Flag-IRF3 plasmids for 36 h. The cells were processed, immunoprecipitated with anti-Flag antibody, and analyzed using Western blotting with anti-Flag, anti-GFP, or anti-β-actin antibody. (D) HEK-293T cells were cotransfected with GFP-P, GFP-P (101 to 200 aa), GFP-P (201 to 295 aa), or GFP-P (101 to 295 aa) and Flag-IRF3 plasmids for 36 h. The cells were processed, immunoprecipitated with anti-Flag antibody, and analyzed using Western blotting with anti-Flag, anti-GFP, or anti-β-actin antibody.
Techniques Used: Immunoprecipitation, Western Blot

Figure Legend Snippet: The effect of P protein on degradation or phosphorylation of IRF3. (A) HEK-293T cells transfected with different doses of expression plasmid P (GFP-P) or GFP. At 36 hpt, the cells were processed, and the expression of IRF3, GFP-tag protein, and β-actin was measured using Western blotting. (B) HEK-293T cells were transfected with expression plasmid P (GFP-P) or empty plasmid (GFP). After 24 h, the cells were transfected with poly (I·C) for 12 h and analyzed using Western blotting for p-IRF3, IRF3, GFP-P, GFP, and β-actin.
Techniques Used: Transfection, Expressing, Plasmid Preparation, Western Blot

Figure Legend Snippet: aMPV/C P protein blocks IRF3 nuclear translocation. (A) HEK-293T cells were transfected with expression plasmid P (GFP-P) or empty plasmid (GFP) for 24 h and subsequently transfected with poly (I·C) for 12 h. Cytoplasmic extracts and nuclear extracts were extracted and detected using Western blotting for p-IRF3, IRF3, GFP-P, GFP, and β-actin. (B) A549 cells were transfected and treated with poly (I·C), as described in the legend to panel A. Cells were stained with anti-IRF3 antibody. Cell nuclei were stained with DAPI (blue). Images were obtained using confocal microscopy. Scale bars, 20 μm.
Techniques Used: Translocation Assay, Transfection, Expressing, Plasmid Preparation, Western Blot, Staining, Confocal Microscopy
p irf3 (Cell Signaling Technology Inc)


Structured Review
P Irf3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p irf3/product/Cell Signaling Technology Inc
Average 96 stars, based on 1 article reviews
Price from $9.99 to $1999.99